Determination of Hepatitis B Antibody Titration and Related Factors in Dental Students in Guilan University of Medical Sciences

Document Type : Original Article

Authors

1 School of Dentistry, Guilan University of Medical Sciences, Rasht, Iran

2 Department of Oral Medicine, School of Dentistry, Guilan University of Medical Sciences, Rasht, Iran

Abstract

Background and aim: As Hepatitis B is a viral infectious disease that transmits through blood, the purpose of this study was to evaluate the antibody titration against hepatitis B and its related factors in dental students at Guilan University of Medical Sciences in 2017.
Materials and methods: This was a descriptive and cross-sectional study. Blood samples were taken from each student, and the anti-hepatitis B antibody titrated. Data analyzed by SPSS Ver22 software. First, the standard variables determined by the Kolmogorov-Smirnov test. For analysis of variables, the T-test, Chi-square, and Fisher's exact test used. In all experiments, P Results: The mean age of men and women was 23.71 ± 1.75 and 22.73 ± .086. The anti-hepatitis B antibody titration was more than 100 mIU/ml in 47 samples. In the 21 samples, the antibody titration was between 10-100 mIU/ml, and in 21 samples, the antibody titration was less than mIU/ml 10. There was a significant relationship between the titration of anti-hepatitis B antibody and the gender, the duration of receiving the vaccine, the number of doses of the vaccine, and also with needle stick received.
Conclusion: The study showed that, despite receiving the hepatitis B vaccine, but a relatively high percentage of students did not have an adequate level of immunity.

Keywords

Main Subjects


  1. Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection-an update. Microbial Cell. 2016; 3 (9):
  2. Jacobson J, La Turno D, Johnston F, Shipman C. Cost effectiveness of prevaccination screening for hepatitis B antibody. Journal of dental education. 1987; 51 (2): 94-7.
  3. Kabir A, Pazouki A, Jafari M, Mokhber S, Vaziri M, Alavian SM. Comparing anti-hepatitis B antibody level in Iranian obese or overweight with non-obese cases. Iranian biomedical journal. 2017; 21(3):197.
  4. Sharifi, Mojabi B, Ketayoun, Farhang , Mostajeri et al. Prevalence against Hepatitis and AIDS viruses in dentists in Qazvin. Iranian Journal of Microbiology. 2008; 2 (2): 55-61.
  5. Sandhu P, Haque M, Humphries-Bickley T, Ravi S, Song J. Hepatitis B virus immunopathology, model systems, and current therapies. Frontiers in immunology. 2017; 8: 436.
  6. Sher R, Mackay M, Macnab G, Kok S, Koornhof H. Hepatitis B antigen, hepatitis B antibody, and subtypes in leprosy. Infection and immunity. 1977; 17 (1): 1-3.
  7. Allain JP, Opare-Sem O. Screening and diagnosis of HBV in low-income and middle-income countries. Nature reviews Gastroenterology & hepatology. 2016; 13 (11): 643-53. doi: 10.1038/ nrgastro. 2016. 138.
  8. Furuncuoglu Y, Bolukbas FF, Bolukbas C, Torun P, Ozturk R. Changes in the prevalence of HBV infection in pregnant women in Turkey between 1995 and 2015: a 20-year evaluation. Postgraduate medical journal. 2016; 92 (1091): 510-3. doi: 10. 1136/ postgradmedj-2015-133876.
  9. Musa BM, Bussell S, Borodo MM, Samaila AA, Femi OL. Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: a systematic review and meta-analysis. Nigerian journal of clinical practice. 2015; 18 (2): 163-72. doi: 10.4103/1119-3077.151035.
  10. Watanabe T, Tokumoto Y, Hirooka M, Koizumi Y, Tada F, Ochi H et al. An HBV-HIV Co-infected Patient Treated with Tenofovir-based Therapy who Achieved HBs Antigen/ Antibody Seroconversion. Internal Medicine. 2014; 53 (12): 1343- 6.
  11. Yağcı M, Suyanı E, Çakar MK. The impact of chemotherapy on hepatitis B antibody titer in patients with hematological malignancies. Turkish Journal of Hematology. 2015; 32 (3): 251.
  12. Das K, Xiong X, Yang H, Westland CE, Gibbs CS, Sarafianos SG et al. Molecular modeling and biochemical characterization reveal the mechanism of hepatitis B virus polymerase resistance to lamivudine (3TC) and emtricitabine (FTC). Journal of virology. 2001; 75 (10): 4771-9.
  13. Stuyver L, De Gendt S, Van Geyt C, Zoulim F, Fried M, Schinazi RF et al. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. Journal of general virology. 2000; 81 (1): 67-74.
  14. Kwon SY, Lee CH. Epidemiology and prevention of hepatitis B virus infection. The Korean journal of hepatology. 2011; 17 (2): 87.
  15. Mast EE, Williams IT, Alter MJ, Margolis HS. Hepatitis B vaccination of adolescent and adult high-risk groups in the United States. Vaccine. 1998; 16: S27-S9.
  16. Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World journal of gastroenterology: WJG. 2007; 13 (1): 22.
  17. Feldman RE, Schiff ER. Hepatitis in dental professionals. JAMA. 1975; 232 (12): 1228-30.
  18. Hegge FN, Tuna N, Burchell HB. Coronary arteriographic findings in patients with axis shifts or ST-segment elevations on exercise-stress testing. American heart journal. 1973; 86 (5): 603-15.
  19. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics—2013 update. Circulation. 2013; 127 (1): e6-e245.
  20. Zipes DP. Braunwald's heart disease: a textbook of cardiovascular medicine. BMH Medical Journal-ISSN 2348–392X. 2018.
  21. Browne R, Chernesky M, Moseley HS, White HSC. Hepatitis B antibody levels in health-care workers of a large general hospital in Barbados. West Indian med j. 1988; 37 (1): 9-11.
  22. Asgharian, Afzali. Hepatitis B antibody testimony in nursing students in Besat Hospital, Nahaja Hospital in 2009. Avicenna. 2010; 12 (4): 21-4.
  23. Andreotti M, Pirillo MF, Liotta G, Jere H, Maulidi M, Sagno JB et al. The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi. BMC infectious diseases. 2014; 14: 180. doi: 10. 1186/ 1471- 2334- 14- 180.
  24. Yassin MH, Gupta V. Role of infection control in prevention of hepatitis B virus (HBV) in hemodialysis (HD) patients. Infectious disorders drug targets. 2013; 13 (3): 162-8.
  25. Habibiyan R. Efficacy of complete hepatitis B-vaccination in health care workers. Journal of Shahrekord Uuniversity of Medical Sciences. 2003; 5.
  26. Habibi, Moussulian. Anti-hepatitis B antibody level after vaccination among clinical students of Islamic Azad University of Mashhad in 2012-2014. Medical Sciences 2013; 3 (1): 1-10.
Volume 1, Issue 3
September 2019
Pages 40-47
  • Receive Date: 21 July 2019
  • Revise Date: 30 August 2019
  • Accept Date: 05 September 2019
  • First Publish Date: 05 September 2019